Hikal informs about unaudited financial results

24 Oct 2018 Evaluate

Hikal has informed that the meeting of the Board of Directors of the Company is scheduled on 01/11/2018, to consider and approve unaudited financial results for quarter ended 30th September 2018.

The above information is a part of company’s filings submitted to BSE.

Hikal Share Price

289.30 -5.60 (-1.90%)
07-May-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1515.15
Dr. Reddys Lab 6277.10
Cipla 1388.00
Zydus Lifesciences 980.65
Lupin 1610.55
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.